政策推动价值回归，自由现金流ETF（159201）近20个交易日合计“吸金”超9.6亿元

Group 1 - The core viewpoint of the article highlights the positive performance of the Guozheng Free Cash Flow Index and the increasing interest in related ETFs, indicating a favorable market environment for companies with high free cash flow [1] - The Guozheng Free Cash Flow Index experienced a recovery after an initial decline, with constituent stocks like Huaren Health hitting the daily limit, and other stocks such as Yixin Tang, Fujian Gaoshu, and Wewei Co. also seeing gains [1] - The largest free cash flow ETF (159201) has attracted over 960 million yuan in net inflows over the past 20 trading days, reflecting strong investor interest [1] Group 2 - According to Song Zhiping, President of the China Listed Companies Association, recent policy measures aimed at "strengthening patient capital" have provided institutional support for guiding medium- and long-term funds into the market since the Central Political Bureau meeting in 2024 [1] - Since 2025, various types of medium- and long-term funds have net purchased over 600 billion yuan in A-shares, serving as a stabilizing force against market volatility and promoting value recovery [1] - The free cash flow ETF (159201) and its linked funds closely track the Guozheng Free Cash Flow Index, focusing on companies with high free cash flow rates, making it a quality investment choice with growth potential and policy certainty [1]